Lobbying Relationship

Client

Pernix Therapeutics

More records

Lobbying firm

BGR Government Affairs

More records

  • Provide advice, counsel, and as appropriate direct advocacy services related to public policies impacting the biopharmaceutical industry generally, and Pernixs priorities and product portfolio specifically.

Duration: to

General Issues: Health Issues

Spending: about $330,000 (But it's complicated. Here's why.)

Agencies lobbied since 2015: U.S. Senate, House of Representatives

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Dave Boyer Sp Asst Pres LA, Asst Comm Leg, FDA, Sp Asst to Sec HHS, Con Asst, Off of WH Liaison DoD, Con Asst, Off of Sec Lab See prior filing
Ryan Long LC Rep Norwood; LA & LD Rep Barton;Prof. Staff, Csel, & Chief Csel Hse E&C Ctme See prior filing
Brent Del Monte LA/LD Rep. Tom Bliley; Counsel House E&C Committee See prior filing

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Registration
Q2 Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page